Statements of Operations-Additional Information (Tables)

9 Months Ended

Mar. 31, 2024

Statements of Operations-Additional Information

Schedule of revenues disaggregated by major product category and geographic region

Net Sales by Product Type

	Three Months				Nine Months
For the Periods Ended March 31	2024		2023		2024		2023
Animal Health
MFAs and other	$	108,216	$	93,217	$	304,261	$	283,186
Nutritional specialties		40,194		45,016		121,840		127,926
Vaccines		32,923		26,201		88,866		71,984
Total Animal Health	$	181,333	$	164,434	$	514,967	$	483,096
Mineral Nutrition		64,228		62,922		181,601		184,212
Performance Products		17,662		18,317		47,947		55,532
Total	$	263,223	$	245,673	$	744,515	$	722,840

Net Sales by Region

	Three Months				Nine Months
For the Periods Ended March 31	2024		2023		2024		2023
United States	$	159,314	$	148,529	$	431,083	$	433,716
Latin America and Canada		53,653		53,881		177,539		159,946
Europe, Middle East and Africa		33,175		28,174		89,572		85,518
Asia Pacific		17,081		15,089		46,321		43,660
Total	$	263,223	$	245,673	$	744,515	$	722,840

Schedule of interest expense, net

	Three Months				Nine Months
For the Periods Ended March 31	2024		2023		2024		2023
Interest expense, net
2021 Credit Facilities	$	5,127	$	4,517	$	15,421	$	12,316
2022 Term Loan		215		191		648		379
Amortization of debt issuance costs		260		188		780		514
Other		43		10		164		20
Interest expense		5,645		4,906		17,013		13,229
Interest income		(1,070)		(1,035)		(3,215)		(2,407)
	$	4,575	$	3,871	$	13,798	$	10,822

Schedule of depreciation and amortization

	Three Months				Nine Months
For the Periods Ended March 31	2024		2023		2024		2023
Depreciation and amortization
Depreciation of property, plant and equipment	$	6,770	$	6,067	$	19,638	$	18,177
Amortization of intangible assets		2,426		2,422		7,339		7,261
	$	9,196	$	8,489	$	26,977	$	25,438